Effects of ambroxol hydrochloride on the levels of inflammatory factors such as TNF-and hs-CRP in patients with severe pneumonia
10.3969/j.issn.1005-1678.2017.05.115
- VernacularTitle:盐酸氨溴索对重症肺炎TNF-α、hs-CRP等炎症因子水平变化的影响及临床疗效分析
- Author:
Shaobo XU
;
Xuelan LIU
;
Jian JIANG
- Keywords:
ambroxol;
pneumonia;
inflammatory cytokines;
pulmonary function
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(5):341-343
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the therapeutic effect of ambroxol hydrochloride on severe pneumonia, and the influence on the inflammatory cytokines of TNF-alpha and hs-CRP etc.MethodsThe clinical data of severe pneumonia patients treated in ningbo city medical treatment center Lihuili hospital from December 2014 to August 2016 were retrospectively analyzed.According to the treatment methods are divided into control group and observation group, the control group was given routine treatment, the observation group in the conventional treatment based on the given of ambroxol hydrochloride.To observe the therapeutic effect of two groups, the differences of serum levels of inflammatory cytokines, pulmonary function, cough and expectoration symptom scores of the two groups were compared before and after treatment.ResultsThe effective rate of the observation group was 97.50%, which was significantly higher than that of the control group;Two groups of patients before treatment serum inflammatory cytokines level no difference, after treatment, the observation group IL-6, IL-8, hs-CRP and TNF-alpha water average lower than the control group;Two groups of patients before treatment pulmonary function index no difference, after treatment, the observation group FVC, FEV1 and FEV1/FVC levels were higher than the control group;Two groups of patients with symptoms of no difference before treatment after treatment, observation group cough, sputum volume, cough ease and wheezing scores were lower than the control group.ConclusionAmbroxol hydrochloride has a good therapeutic effect on severe pneumonia can be significantly reduced in patients with TNF-hs-CRP alpha, inflammatory cytokine levels, improve the symptoms and signs, has good application value.
